Fathom Therapeutics

Fathom Therapeutics is a drug design company that uses physics-based simulations and AI to design novel small molecules by modeling protein motion at atomic resolution[1].

Funding

• Series A, $47MApr 28, 2026

  with Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, Empire State Development’s NY Ventures

Backers

• FAlexandria Venture Investments
• Chemistry

  San Francisco early-stage venture firm founded by investors from Bessemer, a16z and Index, investing in AI and automation, fintech, healthcare and physical intelligence.

• FEmpire State Development’s NY Ventures
• FSutter Hill Ventures

Something wrong or missing? Send a correction. Fixed within 24 hours.